Title: The surge of single-use, Emerging one-and-done solutions for pharma

The rise of single-use technologies (SUT) in pharma has shown no signs of abating and is continuing to transform every area of operations. “The global single-use bioprocessing market was valued at $12.6 billion in 2019 and is projected to witness a CAGR of 12.8 percent by 2027,” says Mark A. Sitcoske, CEO of High Purity New England. “SUT continues to experience huge growth in 2020 in pre-commercial manufacturing, including preclinical and clinical scale systems for upstream processing, such as single-use media bags, bioprocess containers and mixers.” In addition to preclinical applications, pharma is turning to…

Click Here For Complete Article Text


   Person Information
   Application Sequencing
 325412 - Pharmaceutical Preparation Manufacturing                
Company  Product  Process  Other  Subjects  Event  Event  Date  Location  Publication  Publication  Date Text  Descriptor

  • Manufacturing

  • Single-Use Technology





  • Pharma Manufacturing


  • 6/1/2020


  • Article